Walgreen Sales Dip After Express Scripts Contract Ends
Drugstore chain Walgreen (NYSE: WAG) saw a steeper-than-expected decline in February drug volume, the second month it hasn't filled prescriptions for customers in the Express Scripts (NASDAQ: ESRX) network.
The No. 1 drug chain said total February sales climbed 1.5% to $5.86 billion, including this year's extra day.
General merchandise sales at stores open at least a year climbed 2%, despite a slight decrease in traffic. But same-store prescriptions sales fell....
Read the full story at Investor's Business Daily here
The following article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.